![Chenyang Shi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chenyang Shi
Directeur/Bestuurslid bij GENSCRIPT BIOTECH CORPORATION
Profiel
Chenyang Shi was the founder of NuProbe USA, Inc., a company founded in 2016, where he held the title of Chief Executive Officer.
He is currently working as an Independent Non-Executive Director at Genscript Biotech Corp.
since 2024.
Dr. Shi has a graduate and doctorate degree from Rochester Christian University.
He also holds an undergraduate degree from the University of Science & Technology of China, which he received in 1986.
Actieve functies van Chenyang Shi
Bedrijven | Functie | Begin |
---|---|---|
GENSCRIPT BIOTECH CORPORATION | Directeur/Bestuurslid | 12-04-2024 |
Eerdere bekende functies van Chenyang Shi
Bedrijven | Functie | Einde |
---|---|---|
NuProbe USA, Inc.
![]() NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Oprichter | - |
Opleiding van Chenyang Shi
Rochester Christian University | Doctorate Degree |
University of Science & Technology of China | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENSCRIPT BIOTECH CORPORATION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
NuProbe USA, Inc.
![]() NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Commercial Services |